Phenmetrazine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for phenmetrazine hydrochloride and what is the scope of patent protection?
Phenmetrazine hydrochloride
is the generic ingredient in one branded drug marketed by Boehringer Ingelheim and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for phenmetrazine hydrochloride
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 2,602 |
| DailyMed Link: | phenmetrazine hydrochloride at DailyMed |
Medical Subject Heading (MeSH) Categories for phenmetrazine hydrochloride
US Patents and Regulatory Information for phenmetrazine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 011752-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET;ORAL | 010460-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 011752-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
